MEK5 overexpression is associated with the occurrence and development of colorectal cancer

被引:0
|
作者
Dechang Diao
Lei Wang
Jin Wan
Zhiqiang Chen
Junsheng Peng
Huanliang Liu
Xinlin Chen
Wei Wang
Liaonan Zou
机构
[1] Guangdong Provincal Hospital of Traditional Chinese Medicine,Department of Gastrointestinal Surgery
[2] Institute of Gastroenterology,Department of Gastrointestinal Surgery
[3] Sun Yat-Sen University,Department of Preventive Medicine and Medical Statistics, College of Fundamental Medical Science
[4] the Sixth Affiliated Hospital,undefined
[5] Sun Yat-sen University,undefined
[6] Key Laboratory of Tropical Disease Control (Sun Yat-sen University),undefined
[7] Ministry of Education,undefined
[8] Guangzhou,undefined
[9] Guangzhou University of Traditional Chinese Medicine,undefined
来源
BMC Cancer | / 16卷
关键词
MEK5; Colorectal cancer; Univariate analyses; RNA interference; Tumor growth;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Design, synthesis, and testing of orthoamido diphenylamines as inhibitors of MEK5
    Flaherty, Patrick T.
    Chopra, Ishveen
    Diwan, Anubhav
    Monlish, Darlene A.
    Cavanaugh, Jane E.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [32] Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress
    Tusa, Ignazia
    Menconi, Alessio
    Tubita, Alessandro
    Rovida, Elisabetta
    CELLS, 2023, 12 (08)
  • [33] MEK5/ERK5 activation regulates colon cancer stem-like cell properties
    Pereira, Diane M.
    Gomes, Sofia E.
    Borralho, Pedro M.
    Rodrigues, Cecilia M. P.
    CELL DEATH DISCOVERY, 2019, 5 (1)
  • [34] Novel thiophene analogs as potential MEK5/ERK5 inhibitor
    Gupta, Mohit
    Flaherty, Patrick
    Bhatt, Akshita
    Wright, Thomas
    Cavanaugh, Jane
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [35] Abnormal expression of mitogen-activated protein kinase kinase-5 (MEK5) in human prostate cancer
    Mehta, PE
    Brown, R
    Thilak, L
    Pulimood, AB
    Robson, CN
    Neal, DE
    Leung, HY
    BRITISH JOURNAL OF CANCER, 2001, 85 : 87 - 87
  • [36] A network-based drug prioritization and combination analysis for the MEK5/ERK5 pathway in breast cancer
    Regan Odongo
    Asuman Demiroglu-Zergeroglu
    Tunahan Çakır
    BioData Mining, 17
  • [37] Dual role of MEK1/2 and MEK5 in the reversal of epithelial-to-mesenchymal transition
    Hoang, Van T.
    Elliott, Steven
    Martin, Elizabeth C.
    Rhodes, Lyndsay V.
    Segar, Henry C.
    Burks, Hope
    Chakrabarty, Suravi
    Monlish, Darlene
    Phamduy, Theresa B.
    Chrisey, Doug
    Cavanaugh, Jane E.
    Flaherty, Patrick
    Collins-Burow, Bridgette M.
    Burow, Matthew E.
    CANCER RESEARCH, 2014, 74 (19)
  • [38] A network-based drug prioritization and combination analysis for the MEK5/ERK5 pathway in breast cancer
    Odongo, Regan
    Demiroglu-Zergeroglu, Asuman
    Cakir, Tunahan
    BIODATA MINING, 2024, 17 (01)
  • [39] Overexpression of sortilin is associated with 5-FU resistance and poor prognosis in colorectal cancer
    Blondy, Sabrina
    Talbot, Hugo
    Saada, Sofiane
    Christou, Niki
    Battu, Serge
    Pannequin, Julie
    Jauberteau, Marie-Odile
    Lalloue, Fabrice
    Verdier, Mireille
    Mathonnet, Muriel
    Perraud, Aurelie
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (01) : 47 - 60
  • [40] Aberrant MEK5 signalling promotes clear cell renal cell carcinoma development via mTOR activation
    Li, Fangzhou
    Peng, Xufeng
    Zhou, Jiale
    Chen, Qi
    Chen, Yonghui
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (12) : 3257 - 3266